Medical News

RSS

NAFC strives to support and educate nation's injured veterans

The National Association For Continence, with targeted donations from the public, will support and educate our nation's injured veterans, about management and treatment options, through its educational materials about intermittent self-catheterization and continence care following spinal cord injuries.

28 May 2010

Scientists study interaction between Notch signaling pathway and BCL6 gene to understand how cancer forms

A Florida State University College of Medicine researcher has discovered a new interaction between a cell signaling system and a specific gene that may be the cause of B-cell lymphoma. The finding suggests a similar interaction could be occurring during the development of other types of cancer, leading to further understanding of how cancer works — and how it might be stopped.

28 May 2010

Progenics presents preclinical data on novel monoclonal antibodies against toxins produced by C. difficile

Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.

28 May 2010

UT Southwestern researchers create 35 new rat "lines" with mutations in specific genes

For two decades, the laboratory mouse has been the workhorse of biomedical studies and the only mammal whose genes scientists could effectively and reliably manipulate to study human diseases and conditions.

28 May 2010

State-of-the-art heart pump lowers risk for infection in end-stage cardiac patients: Researchers

A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device, according to researchers at Henry Ford Hospital in Detroit.

28 May 2010

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.

28 May 2010

Healthy relationship with food will lead to a better, more promising future for children

The first lady has kicked off a national campaign that charges young Americans to "get up and move," changing the life goals of the newest generation. While the campaign and message are a strong effort, a national epidemic can only be changed with a personal choice to live better. It all starts with one parent, one effort, to take the time to live healthier, to want your children to live healthier. It's more than the number on a scale; it's a way of life.

28 May 2010

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

The disease-causing bacterium E. coli O157:H7 is present but rare in some wildlife species of California's agriculturally rich Central Coast region, an area often referred to as the nation's "salad bowl," reports a team or researchers led by a UC Davis scientist.

28 May 2010

Smartfish announces second distribution partnership with Mobility Lab for ErgoMotion technology

Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.

28 May 2010

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

28 May 2010

IPS Research joins SAFE-BioPharma Association

IPS Research Company, a major southwest clinical research investigator site located in Oklahoma City, OK, has joined SAFE-BioPharma Association and taken another step in the process of eliminating paper copies from its operations.

28 May 2010

Shah outlines U.S. food security partnership with Bangladesh

USAID Administrator Rajiv Shah on Wednesday at the Food Security Investment Forum outlined U.S. plans for its food security partnership with Bangladesh as part of the Feed the Future initiative, the Daily Star reports. The goal of the two-day forum was "to help Bangladesh finalise a roadmap for future investments in food and agriculture," the publication writes (5/27).

28 May 2010

New study examines internal and external uses of health outcomes data for promotional purposes

Health outcomes data can be an important promotional/commercial tool for the biopharma industry, but approaches differ company to company as the marketplace continues to evolve. A new study by Best Practices, LLC examines internal and external uses of health outcomes data for promotional purposes.

28 May 2010

Orthopedic surgeons plan to reduce usage of metal-on-metal hip implants: Survey

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that 25% of the 150 orthopedic surgeons surveyed in its newest Physician Forum publication plan to reduce their usage of metal-on-metal hip implants over the next twelve months.

28 May 2010

MSF report warns of effects of international donor 'backtracking' in global fight against HIV/AIDS

"Backtracking by international donors in funding for HIV/AIDS may undermine years of progress and is already putting lives at risk," according to a report released Thursday by Medecins Sans Frontieres, Reuters reports (Kelland, 5/27).

28 May 2010

Alimera Sciences provides new data from Iluvien Phase 3 FAME clinical trials for DME

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that a new analysis of data from its Phase 3 (FAME) clinical trials for Iluvien, the company's investigational intravitreal insert being studied for diabetic macular edema (DME), indicates that patient vision continues to improve significantly over 30 months.

28 May 2010

Alcohol-related mortality increases in socioeconomically deprived areas of England and Wales

Researchers at the University of Sheffield have found that there are substantially increased death rates from alcohol-related diseases in socioeconomically deprived areas of England and Wales.

28 May 2010

Amnesty International report highlights health care access among global human rights abuses

Millions of people worldwide face repression and human rights abuses, including the denial of health care access, Amnesty International said in its annual report on human rights, which was released on Wednesday, msnbc.com reports (5/26).

28 May 2010

Researchers study safety and immunogenicity of two H1N1 vaccines in UK children

The first head to head study of the two H1N1 vaccines used in the UK during the recent pandemic finds that the adjuvanted split virus vaccine induced higher immune response rates in young children, but was associated with more reactions than the whole virus vaccine.

28 May 2010

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.

28 May 2010

Medical News

NAFC strives to support and educate nation's injured veterans

Scientists study interaction between Notch signaling pathway and BCL6 gene to understand how cancer forms

Progenics presents preclinical data on novel monoclonal antibodies against toxins produced by C. difficile

UT Southwestern researchers create 35 new rat "lines" with mutations in specific genes

State-of-the-art heart pump lowers risk for infection in end-stage cardiac patients: Researchers

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Healthy relationship with food will lead to a better, more promising future for children

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

Smartfish announces second distribution partnership with Mobility Lab for ErgoMotion technology

Restricting salt intake helps control blood pressure in dialysis patients: Research

IPS Research joins SAFE-BioPharma Association

Shah outlines U.S. food security partnership with Bangladesh

New study examines internal and external uses of health outcomes data for promotional purposes

Orthopedic surgeons plan to reduce usage of metal-on-metal hip implants: Survey

MSF report warns of effects of international donor 'backtracking' in global fight against HIV/AIDS

Alimera Sciences provides new data from Iluvien Phase 3 FAME clinical trials for DME

Alcohol-related mortality increases in socioeconomically deprived areas of England and Wales

Amnesty International report highlights health care access among global human rights abuses

Researchers study safety and immunogenicity of two H1N1 vaccines in UK children

Regulus Therapeutics obtains rights to intellectual property covering methods for modulating microRNA-21

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Redefining control and consistency in anaerobic microbiome workflows

Latest News